SLC2A1 and neoplasm: Additionally, using an orthotopic mouse model of PDAC, we demonstrated that macrophages from tumor-bearing mice exhibited elevated glycolysis, and macrophage-specific deletion of glucose transporter 1 (GLUT1) significantly reduced tumor burden [10].